This 2013 US issued patent is for the invention of a stable broad-spectrum antiviral. Viral examples include influenza virus (types A, B and C), avian influenza virus, norovirus (feline calicivirus), human papillomavirus (HPV: pathogen of condyloma acumi natum), coxsackievirus (pathogen of hand-foot-and-mouth 30 disease, aseptic meningitis, Summer cold, febrile disorder, paralysis, and respiratory tract disease), AIDS virus (HIV). hepatitis B virus, canine parvovirus, rotavirus, HHV-1 (her pes simplex virus type 1 (HSV-1)), HHV-2 (herpes simplex virus type 2 (HSV-2)), HHV-3 (varicella-zoster virus (VZV)), 35 HHV-5 (cytomegalovirus (CMV)), virus associated with an ophthalmic field (adenovirus for pharyngoconjunctival fever (pool fever) and epidemic keratoconjunctivitis (pink-eye); and enterovirus for acute hemorrhagic conjunctivitis). This solution maintains its potency for fully effective pharmacological use in humans.
